Evidence map›Paper›PMID 32526850›Full record

ReviewMolecules (Basel, Switzerland)2020

The Potential Therapeutic Value of Medicinal Plants in the Management of Metabolic Disorders.

Trevor T Nyakudya, Thulani Tshabalala, Rachael Dangarembizi, Kennedy H Erlwanger, Ashwell R Ndhlala

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Polyphenol-RichMolecules (Basel, Switzerland) · 2026
    Article
  5. Analysis of Quality Differences inFood science & nutrition · 2026
    Article
  6. Article
  7. Dual PTP1B/DPP4 Inhibitory Potential ofComputational and structural biotechnology journal · 2026
    Article
  8. Antidiabetic Potential ofPlants (Basel, Switzerland) · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Synergistic effects ofHeliyon · 2024
    Article
  16. Investigation ofPlants (Basel, Switzerland) · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Trevor T NyakudyaDepartment of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria 0002, South Africa.ORCID 0000-0003-1872-9257
Thulani TshabalalaAgricultural Research Council (ARC), Vegetable and Ornamental Plants, Private Bag X923, Pretoria 0001, South Africa.ORCID 0000-0003-1735-3761
Rachael DangarembiziDepartment of Human Biology Neuroscience Institute, Faculty of Health Sciences, Division of Physiological Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa.
Kennedy H ErlwangerSchool of Physiology, University of the Witwatersrand, 7 York Road, Parktown 2193, South Africa.ORCID 0000-0001-8058-885X
Ashwell R NdhlalaGreen Technologies Research Centre of Excellence, School of Agricultural and Environmental Sciences, University of Limpopo, Private Bag X1106, Sovenga 0727, South Africa.ORCID 0000-0002-7290-3175
Agricultural Research Council of South Africa · ZAUniversity of Cape Town · ZAUniversity of Limpopo · ZAUniversity of Pretoria · ZAUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MetS) is a prevalent, multifactorial and complex disease that is associated with an increased risk of developing diabetes and other major cardiovascular complications. The rise in the global prevalence of MetS has been attributed to genetic, epigenetic, and environmental factors. The adoption of sedentary lifestyles that are characterized by low physical activity and the consumption of high-energy diets contributes to MetS development. Current management criteria for MetS risk factors involve changes in lifestyle and the use of pharmacological agents that target specific biochemical pathways involved in the metabolism of nutrients. Pharmaceutical drugs are usually expensive and are associated with several undesirable side effects. Alternative management strategies of MetS risk factors involve the use of medicinal plants that are considered to have multiple therapeutic targets and are easily accessible. Medicinal plants contain several different biologically active compounds that provide health benefits. The impact of phytochemicals present in local medicinal plants on sustainable health and well-being of individuals has been studied for many years and found to involve a plethora of complex biochemical, metabolic, and physiological mechanisms. While some of these phytochemicals are the basis of mainstream prescribed drugs (e.g., metformin, reserpine, quinine, and salicin), there is a need to identify more medicinal plants that can be used for the management of components of MetS and to describe their possible mechanisms of action. In this review, we assess the potential health benefits of South African ethnomedicinal plants in protecting against the development of health outcomes associated with MetS. We aim to provide the state of the current knowledge on the use of medicinal plants and their therapeutically important phytochemicals by discussing the current trends, with critical examples from recent primary references of how medicinal plants are being used in South African rural and urban communities.

Indexed as

PhytotherapyAnimalsHumansMetabolic DiseasesPhytochemicalsPlants, MedicinalPhytochemicalsdiabeteshypertensionmedicinal plantsmetabolic syndromenon-alcoholic fatty liver diseaseoxidative stress

Identifiers

PMID32526850
PMCPMC7321241
OpenAlexW3035760298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.